Results 281 to 290 of about 59,203 (302)
Some of the next articles are maybe not open access.

The role of the receptor for advanced glycation end-products in lung fibrosis

American Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
The pathogenesis of pulmonary fibrosis remains unclear. The receptor for advanced glycation end-products (RAGE) is a multi-ligand receptor known to be involved in the process of fibrotic change in several organs, such as peritoneal fibrosis and kidney fibrosis. The aim of this study was to examine the contribution of RAGE during the acute inflammation
Mei, He   +6 more
openaire   +2 more sources

Receptor for advanced glycation end-product in ischemia-reperfusion injury

International Immunopharmacology
Ischemia-reperfusion injury (IRI) serves as a pivotal pathological mechanism underlying tissue damage in diverse clinical scenarios, particularly in organ transplantation, and cardiovascular surgery. A key factor in this process is the inflammatory response triggered by the receptor for advanced glycation end-products (RAGE).
Xi, Luo   +3 more
openaire   +2 more sources

Sulforaphane inhibits advanced glycation end product–induced pericyte damage by reducing expression of receptor for advanced glycation end products

Nutrition Research, 2014
Advanced glycation end products (AGEs) not only inhibit DNA synthesis but also play a role in diabetic retinopathy by evoking apoptosis and inflammation in retinal pericytes via interaction with a receptor for AGE (RAGE). Similarly, sulforaphane, which is a naturally occurring isothiocyanate that is found in widely consumed cruciferous vegetables ...
Sayaka, Maeda   +4 more
openaire   +2 more sources

The receptor for advanced glycation end product (RAGE) pathway in COVID-19

Biomarkers, 2021
Mustafa Cihangiroğlu   +2 more
exaly  

Plasma Levels of Receptor for Advanced Glycation End Products, Blood Transfusion, and Risk of Primary Graft Dysfunction

American Journal of Respiratory and Critical Care Medicine, 2009
Jason D Christie   +2 more
exaly  

Home - About - Disclaimer - Privacy